X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs NOVARTIS - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD NOVARTIS MERCK LTD/
NOVARTIS
 
P/E (TTM) x 26.1 347.8 7.5% View Chart
P/BV x 2.9 17.1 17.1% View Chart
Dividend Yield % 1.0 1.7 57.4%  

Financials

 MERCK LTD   NOVARTIS
EQUITY SHARE DATA
    MERCK LTD
Dec-16
NOVARTIS
Mar-16
MERCK LTD/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs1,060982 107.9%   
Low Rs623556 112.0%   
Sales per share (Unadj.) Rs632.4252.9 250.1%  
Earnings per share (Unadj.) Rs45.762.1 73.6%  
Cash flow per share (Unadj.) Rs62.363.3 98.5%  
Dividends per share (Unadj.) Rs11.0010.00 110.0%  
Dividend yield (eoy) %1.31.3 100.5%  
Book value per share (Unadj.) Rs388.8363.6 106.9%  
Shares outstanding (eoy) m16.6031.96 51.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.0 43.8%   
Avg P/E ratio x18.412.4 148.7%  
P/CF ratio (eoy) x13.512.2 111.1%  
Price / Book Value ratio x2.22.1 102.3%  
Dividend payout %24.116.1 149.5%   
Avg Mkt Cap Rs m13,96924,580 56.8%   
No. of employees `0001.60.8 210.5%   
Total wages/salary Rs m1,4871,801 82.5%   
Avg. sales/employee Rs Th6,631.910,748.9 61.7%   
Avg. wages/employee Rs Th939.22,395.2 39.2%   
Avg. net profit/employee Rs Th479.42,641.1 18.2%   
INCOME DATA
Net Sales Rs m10,4988,083 129.9%  
Other income Rs m242829 29.2%   
Total revenues Rs m10,7418,913 120.5%   
Gross profit Rs m1,135234 484.8%  
Depreciation Rs m27637 750.7%   
Interest Rs m02 0.0%   
Profit before tax Rs m1,1021,025 107.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m343752 45.7%   
Profit after tax Rs m7591,986 38.2%  
Gross profit margin %10.82.9 373.2%  
Effective tax rate %31.173.4 42.5%   
Net profit margin %7.224.6 29.4%  
BALANCE SHEET DATA
Current assets Rs m6,41012,678 50.6%   
Current liabilities Rs m8,8282,433 362.9%   
Net working cap to sales %-23.0126.7 -18.2%  
Current ratio x0.75.2 13.9%  
Inventory Days Days5833 176.4%  
Debtors Days Days3822 170.7%  
Net fixed assets Rs m1,40669 2,032.4%   
Share capital Rs m166160 103.9%   
"Free" reserves Rs m6,28611,460 54.9%   
Net worth Rs m6,45511,621 55.5%   
Long term debt Rs m00-   
Total assets Rs m8,82814,400 61.3%  
Interest coverage xNM570.5-  
Debt to equity ratio x00-  
Sales to assets ratio x1.20.6 211.8%   
Return on assets %8.613.8 62.3%  
Return on equity %11.817.1 68.8%  
Return on capital %17.123.6 72.4%  
Exports to sales %8.30.7 1,112.0%   
Imports to sales %21.018.6 113.2%   
Exports (fob) Rs m86960 1,444.2%   
Imports (cif) Rs m2,2091,503 147.0%   
Fx inflow Rs m959186 514.7%   
Fx outflow Rs m2,6121,821 143.5%   
Net fx Rs m-1,653-1,635 101.1%   
CASH FLOW
From Operations Rs m1,0702,531 42.3%  
From Investments Rs m-750-8,270 9.1%  
From Financial Activity Rs m-150-386 38.8%  
Net Cashflow Rs m171-6,125 -2.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 2.0 910.0%  
FIIs % 1.0 1.6 62.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 21.5 135.3%  
Shareholders   28,591 41,647 68.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  STERLING BIOTECH  NATCO PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS